Skip to main content

Table 1 Laboratory test results 5 days after the first tocilizumab administration

From: Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report

Hematology Biochemistry Immunology  
WBCs 5.76 × 109/L CRP 0.1 mg/L ANA  × 40 (homo)
Neutrophils 73.0% TP 71 g/L IgA 1970 mg/L
Eosinophils 1.0% Alb 36 g/L IgM 1370 mg/L
Basophils 1.0% Urea 3.6 mmol/L IgG 21,490 mg/L
Lymphocytes 21.0% Cr 31 µmol/L β-D glucan  − 
Monocytes 4.0% T-Bil 14 µmol/L Procalcitonin  − 
RBCs 2390 × 109/L AST 38 IU/L T-SPOT  − 
Hb 59 g/L ALT 19 IU/L CMV Ag (C10, 11) (0,0)
Hct 19.9% ALP 246 IU/L Anti-Trichosporon asahii antibody  − 
Platelets 231 × 109/L LDH 612 IU/L Blood gas analysis (nasal oxygen 3 L/min)
MCV 83.3 fL γ-GTP 14 IU/L pH 7.429
MCH 24.7 pg Na 136 mmol/L PaO2 71.1 mmHg
MCHC 29.6% K 4.2 mmol/L PaCO2 33.1 mmHg
Ret 10.1% Cl 105 mmol/L HCO3 21.4 mmol/L
   KL-6 1820 U/mL BE -2.6 mmol/L
   Ferritin 593.7 µg/L   
  1. WBC white blood cell, RBC red blood cell, Hb hemoglobin, Hct hematocrit, MCV mean corpuscular volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, Ret reticulocytes, CRP C-reactive protein, TP total protein, Alb albumin, Cr creatinine, T-Bil total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, LDH lactate dehydrogenase, γ-GTP gamma glutamyl transferase, KL-6 Krebs von den Lungen-6, ANA anti-neutrophil antibody, T-SPOT T-SPOT®.TB test for Mycobacterium tuberculosis, CMV Ag cytomegalovirus antigen, BE base excess